Alzheimer's Disease
Showing of 19 results
National Institute on Aging Awards Expected to Total $21.1 Million to Renew Support for Cleveland Alzheimer’s Disease Research Center
Center is one of 37 NIH-funded Alzheimer’s Disease Research Centers in the nation.
Cleveland Researchers Discover Potential New Treatment for Parkinson’s Disease and Other Neurodegenerative Conditions
New study from University Hospitals, Case Western Reserve University and the Cleveland VA published in Redox Biology.
Cleveland Researchers Discover Nitric Oxide Rewires Gene Expression in the Brain, Offering New Insight into Alzheimer’s Disease
New study from University Hospitals and Case Western Reserve University shows loss of nitric oxide in Alzheimer’s brains; Published in Molecular Cell.
New Study Shows Alzheimer’s Disease Can Be Reversed in Animal Models to Achieve Full Neurological Recovery, Not Just Prevented or Slowed
Researchers from University Hospitals, Case Western Reserve University and the Cleveland VA showed restoring the brain’s energy balance led to both pathological and functional recovery.
Potential New Treatment for Alzheimer's Disease, Other Neurodegenerative Conditions
Drug developed by Case Western Reserve, UH and Cleveland VA researchers found to protect ‘guardian of the brain’
UH Cleveland Medical Center Currently Recruiting People with Early Alzheimer’s Disease for a Clinical Trial Evaluating Benfotiamine, a Synthetic Version of Thiamine (Vitamin B1)
Phase 2 study funded by the National Institute on Aging, part of the NIH, is evaluating effects of benfotiamine on cognitive function.
Synergy for Change Award to Morgan Stanley GIFT and Harrington Discovery Institute
Award highlights collaboration between for profit and non-profit achieving great impact.
University Hospitals Only Health System in Northeast Ohio Offering FDA-Approved KISUNLA™ for Treatment of Alzheimer’s Disease
UH Brain Health & Memory Center Begins KISUNLA (Donanemab) Infusions for Patients.